A hidden tradeoff in Trump’s MFN drug deals
The government has announced pricing agreements with 26 pharma companies. But the deals could stymie other plans to lower the country’s drug spend.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- A hidden tradeoff in Trump’s drug pricing deals biopharmadive.com